Literature DB >> 27032829

Drug delivery: Nanoparticles improve profile of molecularly targeted cancer drug.

Megan Cully.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27032829     DOI： 10.1038/nrd.2016.60

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo.

Authors:  Susan Ashton; Young Ho Song; Jim Nolan; Elaine Cadogan; Jim Murray; Rajesh Odedra; John Foster; Peter A Hall; Susan Low; Paula Taylor; Rebecca Ellston; Urszula M Polanska; Joanne Wilson; Colin Howes; Aaron Smith; Richard J A Goodwin; John G Swales; Nicole Strittmatter; Zoltán Takáts; Anna Nilsson; Per Andren; Dawn Trueman; Mike Walker; Corinne L Reimer; Greg Troiano; Donald Parsons; David De Witt; Marianne Ashford; Jeff Hrkach; Stephen Zale; Philip J Jewsbury; Simon T Barry
Journal:  Sci Transl Med       Date:  2016-02-10       Impact factor: 17.956
  1 in total
  6 in total

1.  Dual-Mode Mass Spectrometric Imaging for Determination of in Vivo Stability of Nanoparticle Monolayers.

Authors:  S Gokhan Elci; Gulen Yesilbag Tonga; Bo Yan; Sung Tae Kim; Chang Soo Kim; Ying Jiang; Krishnendu Saha; Daniel F Moyano; Alyssa L M Marsico; Vincent M Rotello; Richard W Vachet
Journal:  ACS Nano       Date:  2017-07-13       Impact factor: 15.881

2.  Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.

Authors:  Wei-Liang Chen; Fang Li; Yan Tang; Shu-di Yang; Ji-Zhao Li; Zhi-Qiang Yuan; Yang Liu; Xiao-Feng Zhou; Chun Liu; Xue-Nong Zhang
Journal:  Int J Nanomedicine       Date:  2017-06-06

Review 3.  Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects.

Authors:  Sven Kruspe; Paloma H Giangrande
Journal:  Biomedicines       Date:  2017-08-09

Review 4.  Potential and Challenges of Aptamers as Specific Carriers of Therapeutic Oligonucleotides for Precision Medicine in Cancer.

Authors:  Silvia Nuzzo; Giuseppina Roscigno; Alessandra Affinito; Francesco Ingenito; Cristina Quintavalle; Gerolama Condorelli
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

5.  Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Coadministration of Targeting Ligand.

Authors:  Lei Song; Sarah Able; Errin Johnson; Katherine A Vallis
Journal:  Nanotheranostics       Date:  2017-06-08

6.  Experimental determination of the energy difference between competing isomers of deposited, size-selected gold nanoclusters.

Authors:  D M Foster; R Ferrando; R E Palmer
Journal:  Nat Commun       Date:  2018-04-03       Impact factor: 14.919
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.